Overview
This review describes the epidemiology, pathophysiology, clinical presentation, and management of systemic nickel allergy syndrome (SNAS), which involves both cutaneous and extracutaneous (gastrointestinal, neurologic, rheumatologic) symptoms triggered by ingestion of nickel-containing foods in individuals sensitized to nickel via skin contact. SNAS is a type IV cell-mediated hypersensitivity pathway. The review is relevant to the immunotoxicology topic because it documents dietary nickel as an immune trigger with systemic consequences, identifies nickel-rich food sources, and reviews the EU regulatory limit for nickel in drinking water.
Key numbers
- Prevalence of nickel contact allergy in the European general population: approximately 8% to 19% in adults and 8% to 10% in children and adolescents; strong female predominance (Warshaw et al. 2013, cited in source).
- Patch testing thresholds: contact allergy to nickel 5.0% elicited in 20.3% of tested individuals; 2.5% nickel concentration elicited allergy in 16.8% (Svedman et al., cited in source; P <0.0001).
- EU regulatory limit for nickel in drinking water: 20 microg/L (European Drinking Water Directive, cited in source).
- Nickel-rich foods: chocolate, leafy green vegetables, legumes, beans, soy, nuts, whole wheat, peas, oats, shellfish, and canned food (review synthesis).
- SNAS clinical manifestations: gastrointestinal (nausea, heartburn, diarrhea, abdominal pain, constipation, bloating, irritable bowel syndrome-like disorder), dermatologic (vesicle/bullous hand dermatitis, systemic contact dermatitis), neurologic (headache, fatigue), and rheumatologic (arthralgia, fibromyalgia-like).
- Primary treatment: low-nickel diet; symptom recurrence observed after dietary nickel reintroduction.
- Alternative/adjunct interventions: nickel chelation, systemic medications, and probiotics reviewed in source.
Methods (brief)
Narrative review. Literature drawn from published case-control studies, cohort studies, clinical trials, and case reports on SNAS and nickel contact allergy. The review was prompted by a clinical case of SNAS at Alice L. Walton School of Medicine. No formal meta-analysis; qualitative synthesis with selected quantitative data from cited primary studies. No primary metal measurements; all concentrations are from cited regulatory or epidemiological sources.
Limitations
Review design; no primary exposure measurements. Epidemiological prevalence estimates for nickel allergy are from patch-test studies and are sensitive to the nickel concentration used for testing. The distinction between SNAS and allergic contact dermatitis is clinically challenging and may affect prevalence estimates. Studies on dietary nickel interventions are mostly small and without standardized dosing protocols.
Implications
Certification: Nickel is one of HMT&C’s 10 certified analytes. This review establishes that the dietary route is clinically significant for nickel immune effects (SNAS), with systemic symptoms occurring in sensitized individuals at typical dietary exposures. The EU 20 microg/L drinking water limit and the food list of high-nickel sources inform ingredient-level risk framing.
Courses: Core reference for the nickel module and the dietary allergen-immunotoxicology interface. Useful for explaining why nickel is in a food safety program rather than only an occupational or cosmetic one.
App: Food list (chocolate, legumes, soy, nuts, whole wheat, oats, shellfish, canned food) is relevant for the app’s nickel exposure flagging logic per ingredient. No quantitative concentration data to populate contamination_profile.
Microbiome: Probiotic supplementation in SNAS patients is discussed as an emerging intervention; relevant to WikiBiome entry on nickel-gut interactions.
Related evidence
Update history
No substantive edit history is available in this build. The full commit record is available in git.